What should the burden of proof be for acceptance of a new breast-cancer screening technique?

Lancet. 2004;364(9440):1111-2. doi: 10.1016/S0140-6736(04)17121-3.

Author

Martin J Yaffe¹

Affiliation

¹ Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada M4N 3M5. martin.yaffe@swri.ca

PMID: 15451209
DOI: 10.1016/S0140-6736(04)17121-3

No abstract available

MeSH terms

Breast Neoplasms / diagnosis*
Female
Humans
Magnetic Resonance Imaging
Mammography
Radiographic Image Enhancement
Randomized Controlled Trials as Topic
Risk Factors
Sensitivity and Specificity
Ultrasonography, Mammary